Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

PODCAST: Melanie Storrusten Speaks on the Value of Educating the Family

11/10/2014

Addiction professionals in the Baltimore community and beyond came together on October 30th, to discuss family dynamics in addiction recovery.

The event, produced by Addiction Professional, featured several panelists who provided their insights on the unique challenges and opportunities faced when working with families.

During this podcast Melanie Storrusten, Director, Foundations Atlanta at Midtown discusses the importance of educating the family in order to evoke healthy participation in the recovery process.  

 

Advertisement

News

News
Vertex Prepares to Submit New Drug Application for Medication to Treat Acute Pain
02/01/2024
Tom Valentino, Digital Managing Editor
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive...
02/01/2024
Addiction Professional
News
Sex Hormone Linked to Cocaine Addiction Susceptibility
01/30/2024
Tom Valentino, Digital Managing Editor
A study from the University of Texas at Arlington backs previous research that shows women are more likely than men to develop an addiction to cocaine, try cocaine at a younger age, use larger amounts of the drug, and suffer an overdose.
A study from the University of Texas at Arlington backs previous research that shows women are more likely than men to develop an addiction to cocaine, try cocaine at a younger age, use larger amounts of the drug, and suffer an overdose.
A study from the University of...
01/30/2024
Addiction Professional
News
Study Finds No Significant Link Between Cannabis Use and Relapse in OUD Patients
01/26/2024
Tom Valentino, Digital Managing Editor
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10...
01/26/2024
Addiction Professional
News
Study Explores Use of DBS to Treat Severe Opioid Use Disorder
01/23/2024
Tom Valentino, Digital Managing Editor
Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.
Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.
Allegheny Health Network seeks 2...
01/23/2024
Addiction Professional
News
CMS Announces Model to Integrate Behavioral and Physical Healthcare
01/19/2024
Tom Valentino, Digital Managing Editor
The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.
The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.
The Centers for Medicare &...
01/19/2024
Behavioral Healthcare Executive
News
FDA-Approved Medication Shows Potential to Reduce Surgery Patients’ Need for Opioids
01/15/2024
Tom Valentino, Digital Managing Editor
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study...
01/15/2024
Addiction Professional
News
Reduced Drug Use an “Alternative Valid Outcome” for Individuals With Stimulant Use Disorder
01/11/2024
Tom Valentino, Digital Managing Editor
Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.
Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.
Reducing use of stimulants was...
01/11/2024
Addiction Professional
News
Costs, Scarcity Remain Problematic for Families Seeking Adolescent Residential Addiction Treatment
01/09/2024
Tom Valentino, Digital Managing Editor
New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.
New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.
New research from Oregon Health...
01/09/2024
Addiction Professional
News
Test to Assess OUD Risk in Acute Pain Patients Receives FDA Approval
01/03/2024
Tom Valentino, Digital Managing Editor
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by...
01/03/2024
Addiction Professional
News
Post-Surgery Opioid Prescribing Decline Continues—but at Slower Pace
12/27/2023
Tom Valentino, Digital Managing Editor
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of...
12/27/2023
Addiction Professional

Advertisement

Subscribe

Addiction Professional Newsletter

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement